Search
Discovery led by MSU professor finds two common medicines can fight childhood cancer
- OPACC
- Oct 8, 2015
- 1 min read
Dr. Bachmann, who has a history of finding new uses for old drugs, found in his research that a combination of the drugs DFMO or difluoromethylornithine and sulfasalazine can be used to stop the growth of neuroblastoma, which causes about 15 percent of all deaths from childhood cancer.
Recent Posts
See AllAmong pediatric patients with hematologic malignancies undergoing hematopoietic stem cell transplantation (HSCT), using...
Neuroblastomas are the most common cancer in infants, with about 700–800 diagnoses per year in the US, according to the American Cancer...
Childhood cancer survivors are more likely than the general population to develop chronic health conditions and die before reaching 65...